Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
COLEMAN, ROBERT
One or more keywords matched the following items that are connected to COLEMAN, ROBERT
Item TypeName
Concept Triazoles
Academic Article Adjuvant use of anastrozole in breast cancer.
Academic Article Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.
Academic Article Current and future status of adjuvant therapy for breast cancer.
Academic Article Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
Academic Article Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.
Academic Article Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
Academic Article Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
Academic Article Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.
Academic Article Reply to G. Bogani et al.
Academic Article Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Academic Article Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
Academic Article NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors.
Academic Article Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.
Academic Article Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.
Search Criteria
  • Triazoles